<?xml version="1.0" encoding="UTF-8"?>
<p id="Par45" class="p">Oral administration of ME of cyclosporine A resulted in increased bioavailability with not many side effects in hepatic impaired patients [
 <xref ref-type="bibr" rid="CR86" class="xref">86</xref>] and stable plasma drug concentrations were maintained in renal impaired patients [
 <xref ref-type="bibr" rid="CR87" class="xref">87</xref>]. Oral application of carvedilol loaded NEs has displayed two-fold faster release profile and several folds increase in C
 <sub class="sub">max</sub> and AUC [
 <xref ref-type="bibr" rid="CR88" class="xref">88</xref>]. Thus the particulate emulsified systems are proven to be superior in the treatment of certain ailments though they were orally administered.
</p>
